Navigation Links
ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
Date:11/12/2008

ot improved. Twenty-four (24) subjects have been followed for greater than one year.

Four hundred and forty seven (447) acute attacks were treated in 82 subjects who had at least one attack. The primary locations of treated attacks were extremities (68); facial (48); gastrointestinal (272); genitourinary (9); and laryngeal (50). According to additional study findings, the median time to improvement was 30 minutes in the 447 attacks that occurred, and 93.4 percent of patients reported improvement in symptoms within 4 hours, regardless of how many times they had previously received Cinryze. None of the subjects in this study treated for laryngeal attacks required hospitalization or intubation, and no serious adverse reactions were considered related to Cinryze administration.

New Data Support Need to Improve Screening for HAE

Despite the potential severity of HAE-related attacks, many patients experience significant delays in receiving an accurate diagnosis of HAE, according to recent survey findings that were also presented at the ACAAI Annual Meeting.

HAE patients from the US, UK, France, Germany, and the Netherlands were invited by their local HAE organization to participate in an online, anonymous online survey. The surveys sought to determine patients' family history of HAE, observe the flow of patients through the healthcare system, and identify differences in medical care. Three hundred and thirteen (313) participants, with an average age of 37 years, completed the questionnaire.

Results from this survey were presented in an abstract entitled "Shortcomings in the diagnosis of hereditary angioedema: Are we adequately screening family members of affected patients?" These results indicated that 65 percent of patients were initially misdiagnosed, which resulted in an unnecessary surgical procedure in more than 20 percent of patients. The average time to diagnosis was 8.3 years after initial presentation of symptoms, and patients a
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
2. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
3. ViroPharma Announces Discontinuation of HCV-796 Development
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. ViroPharma to Present at the Natixis Bleichroeder Conference
7. ViroPharma to Present at Three Upcoming Healthcare Conferences
8. Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
9. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
10. Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring
11. Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)...   Memorial Hermann Health System and The ... a new partnership to provide a new level of specialized ... in the greater Houston area. ... exclusive provider of professional breast radiology services for five of ... The Woodlands , Northeast, Southwest and ...
(Date:8/21/2014)... 21, 2014  eRelevance Corporation ( www.erelevancecorp.com ), ... that it has completed integration with Nextech, a ... Surgery and Dermatology practices. "Integration allows ... healthcare practices using Nextech," stated Bob Fabbio ... information from the EMR we are able to ...
(Date:8/21/2014)... 21, 2014 /CNW/ - Eisai Limited is pleased to support ... first-of-its-kind comic book available in Canada . ... specifically to educate children and their parents about epilepsy, the ... affecting more than 300,000 Canadians. Eisai is guided by a ... in which the patient is central – there was a ...
Breaking Medicine Technology:Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2
... , , ROCHESTER, Minn. , Feb. 5 ... to speed the introduction of new medical treatments developed by ... plaguing the clinical trials process: the lack of a systematic, ... burdens associated with trial start-up administration. , Clinical testing of ...
... SOUTH SAN FRANCISCO, Calif. , Feb. 5 Poniard ... oncology therapies, today announced that Ronald Martell , chief executive officer, ... Investor Conference on Tuesday, February 9, 2010 at 1:00 ... York City . , A live audio webcast of the corporate overview ...
Cached Medicine Technology:Centerphase Solutions, Inc. Launches New Clinical Trials Business Model Company 2Centerphase Solutions, Inc. Launches New Clinical Trials Business Model Company 3Centerphase Solutions, Inc. Launches New Clinical Trials Business Model Company 4Poniard Pharmaceuticals to Present at 12th Annual BIO CEO and Investor Conference 2
(Date:8/22/2014)... The New Jersey Institute for Food, ... University of New Jersey has joined forces with ... educate young people about health and nutrition in a ... both organizations. , The partnership will encompass quarterly custom ... and video communications. ChopChop Magazine features plenty of ...
(Date:8/22/2014)... 2014 (HealthDay News) -- The U.S. Drug Enforcement Administration ... painkillers containing hydrocodone, which has been tied to a ... The new restrictions would cover prescription narcotic drugs such ... in the same regulatory class as painkillers such as ... access to a three-month supply of the drug and ...
(Date:8/22/2014)... low levels of nicotine may reduce addiction without ... new study from the University of Waterloo. ... Cancer Epidemiology monitored the smoking behaviours of ... of cigarettes with markedly reduced nicotine levels. , ... of which have very similar levels of nicotine ...
(Date:8/22/2014)... The leather seat covers provided ... experts to meet customers’specific product needs. Recently, the company has ... . , The company wants to provide worldwide clients ... the seat cover industry for a long time. According to ... offered at promotional rates. Among all the new products, ...
(Date:8/22/2014)... 2014 AcousticSheep LLC participated in one ... – the first Color Run – otherwise known as the “Happiest ... 2014 and over 10,900 participants from Erie, surrounding areas, and even ... in one of the largest running events put on in Erie, ... the “Happiest 5K on the Planet.” The event took place on ...
Breaking Medicine News(10 mins):Health News:New Jersey Institute for Food, Nutrition & Health to Launch Innovative Partnership with Award-Winning Children’s Anti-Obesity Organization, ChopChop Kids 2Health News:New Jersey Institute for Food, Nutrition & Health to Launch Innovative Partnership with Award-Winning Children’s Anti-Obesity Organization, ChopChop Kids 3Health News:U.S. to Tighten Access to Certain Narcotic Painkillers 2Health News:U.S. to Tighten Access to Certain Narcotic Painkillers 3Health News:Smokers consume same amount of cigarettes regardless of nicotine levels 2Health News:Custom 1993-1996 Chevrolet Camaro Leather Seat Covers Now for Sale at Lseat.com 2Health News:RunPhones® Reveals Erie, PA Enthusiasm Impressed Color Run Director 2Health News:RunPhones® Reveals Erie, PA Enthusiasm Impressed Color Run Director 3
... , , - Ninety-minute Report ... SMILEY and NIGHTLY BUSINESS REPORT - , , ... a major address on healthcare to a joint session of Congress ... and NIGHTLY BUSINESS REPORT are collaborating to provide a timely and ...
... , , LOS ... Dr. Christina Restrepo has achieved diplomate status with the American College ... Restrepo graduated in 2003 from the University of Florida College of ... small animal medicine and surgery at the renowned Animal Medical Center ...
... , , Actuaries Urge President to ... WASHINGTON, Sept. 8 The American Academy of Actuaries ... is expecting there to be an increase in the number of people without ... According to last year,s Census Bureau estimates, nearly 46 million people were ...
... Only Hospital in Northern and Central California to ... REDWOOD CITY, Calif., Sept. 8 Sequoia Hospital announced that ... ablation procedures, making it the highest total volume A-Fib ablation ... Numerous medical journals and world-wide ablation center surveys have documented ...
... when disease will respond to cancer drug , TUESDAY, Sept. ... into whether certain aggressive cancers -- including those that attack ... certain anti-cancer drug. , The key appears to lie in ... 6 online issue of Nature Medicine . , Researchers ...
... diabetes in children, University of Iowa researchers have discovered ... and insulin secretion. The mechanism involves a protein called ... human heart arrhythmias. The findings, which ... Proceedings of the National Academy of Sciences , ...
Cached Medicine News:Health News:PBS Special on Health Care Reform 2Health News:PBS Special on Health Care Reform 3Health News:PBS Special on Health Care Reform 4Health News:Animal Dermatology Clinic Marina del Rey Announces Dr. Christina Restrepo, DVM Achieves Diplomate Status With the American College of Veterinary Dermatology 2Health News:Actuaries: Unemployment May Boost Number of Uninsured 2Health News:Sequoia Hospital Announces High Volume Cardiac Arrhythmia Program 2Health News:Sequoia Hospital Announces High Volume Cardiac Arrhythmia Program 3Health News:Team reveals molecular mechanism underlying a form of diabetes 2
The safePICO is a prebarcoded arterial sampler that helps you ensure patient and caregiver safety. SafePICO is part of 1st automatic, the worlds first automatic blood gas analysis system....
Non-invasive and continuous tcpCO2 and tcpO2 patient monitoring....
The TCM400 is the first and only portable instrument to provide up to six simultaneous measurements of transcutaneous oxygen tension (tcpO2)...
... automated blood gas analysis system that combines ... steps in the analytical process, improve patient ... 1st automatic system consists of the safePICO ... automatic sample handling system. With 1st automatic, ...
Medicine Products: